MP24-03 REAL-WORLD UTILIZATION OF APALUTAMIDE AND ENZALUTAMIDE IN NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A RETROSPECTIVE STUDY

Sreevalsa Appukkuttan,Keely Madaj,Yuxian Du,John Azzolina,Wanda Wilt,Jacqueline Parkin,J. Partridge,Sheldon Kong,Michael D. Fabrizio

MP24-03 REAL-WORLD UTILIZATION OF APALUTAMIDE AND ENZALUTAMIDE IN NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A RETROSPECTIVE STUDY

2021

Sreevalsa Appukkuttan
Keely Madaj
Yuxian Du
John Azzolina
Wanda Wilt
Jacqueline Parkin
J. Partridge
Sheldon Kong
Michael D. Fabrizio

INTRODUCTION AND OBJECTIVE:Management of non-metastatic castrate-resistant prostate cancer (nmCRPC) has shifted since the approval of three second generation androgen receptor antagonist (ARA), apa...

Keywords:

Oncology
Prostate cancer
Enzalutamide
Medicine
Apalutamide
androgen receptor antagonist
Castrate-resistant prostate cancer
Internal medicine
non metastatic
Retrospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations